Abbott’s shares rose to an all-time high after the device maker beat Wall Street estimates for quarterly sales on higher demand for the company’s nutrition products and generic drugs.
Nutrition connects people around the world and can change lives. This is the concept of the tribute to nutritionists created by FCB Health Brasil for Nestlé Health Science. The idea is to show how nutrition brings people together and creates lasting bonds.
Fresenius Kabi is investing $100 million in expanding the German company’s manufacturing campus in Wilson County, North Carolina, which will add at least 445 new jobs.
Unilever is to buy GlaxoSmithKline’s Horlicks nutrition business for $3.8 billion, boosting the Anglo-Dutch group’s position in India by adding the popular malted drink.
PepsiCo Inc. bought nutritional food company Health Warrior Inc., the latest move in an effort to target consumers who are ditching processed and sugary foods for healthier options.
An estimated 6.3 million children died before their 15th birthdays in 2017 – or one every five seconds – mostly due to a lack of water, sanitation, nutrition and basic healthcare, according to report by United Nations agencies.
GlaxoSmithKline is seeking initial bids by mid-September for the company’s India-focused Horlicks health nutrition business, which is expected to fetch more than $4 billion, two people familiar with the situation said.
Nestle is buying Canadian vitamin maker Atrium Innovations for $2.3 billion, expanding its presence in consumer healthcare.
“As a doctor, father and the head of the U.S. Food & Drug Administration, I believe that everyone is entitled to the information they need to make informed decisions about the food they eat. We serve as the nation’s expert on food labeling, which is why Congress entrusted us with the responsibility of crafting predictable, uniform federal standards that will benefit the health of families across America by ensuring access to essential calorie and nutrition information on food and menu labels.”
GlaxoSmithKline is selling off the UK part of its Horlicks malted milk beverage company as well as its MaxiNutrition sports drink brand. Also as part of a restructuring, GSK halted plans for a biopharmaceutical manufacturing facility in Cumbria, UK, which was expected to cost 350 million pounds.